| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | -38.0% | -12.0% |
| Cost of Revenue | $1.8M | — | -4.2% |
| Gross Profit | -$378K | -200.8% | -42.5% |
| R&D Expense | $3.0M | — | +16.2% |
| SG&A Expense | $2.1M | — | -46.1% |
| Operating Income | -$7.2M | — | +17.9% |
| Pre-tax Income | -$7.1M | — | +18.1% |
| Net Income | -$7.1M | +17.9% | +18.1% |
| EPS (Basic) | -$0.09 | +25.0% | +18.2% |
| EPS (Diluted) | -$0.09 | +25.0% | +18.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.2M | -4.6% | +32.4% |
| Accounts Receivable | $875K | -46.3% | -39.0% |
| Inventory | $1.8M | -17.9% | -58.0% |
| Current Assets | $24.8M | -8.9% | +10.7% |
| Total Assets | $38.4M | -4.2% | +7.3% |
| Current Liabilities | $4.0M | -18.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | -60.9% |
| Capital Expenditures | $996K | — | +62.4% |
| Investing Cash Flow | -$1.2M | — | -53.4% |
| Financing Cash Flow | $5.7M | — | +355.1% |
| Free Cash Flow | -$6.6M | — | -61.1% |
| +37.4% |
| Total Liabilities | $4.4M | -18.8% | — |
| Stockholders' Equity | $24.0M | -2.8% | -26.9% |